Get in on BiomX Inc.’s (PHGE) buy-in window today!

BiomX Inc. (AMEX: PHGE) stock jumped 18.75% on Tuesday to $0.38 against a previous-day closing price of $0.32. With 0.7 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.42 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.4000 whereas the lowest price it dropped to was $0.3220. The 52-week range on PHGE shows that it touched its highest point at $2.14 and its lowest point at $0.13 during that stretch. It currently has a 1-year price target of $5.25. Beta for the stock currently stands at 1.08.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PHGE was up-trending over the past week, with a rise of 33.80%, but this was up by 95.07% over a month. Three-month performance surged to 0.72% while six-month performance fell -50.98%. The stock lost -73.61% in the past year, while it has gained 103.54% so far this year.

Float and Shares Shorts:

At present, 29.91 million PHGE shares are outstanding with a float of 24.17 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.25 million, which was 0.84% higher than short shares on Sep 14, 2022. In addition to Mr. Jonathan Eitan Solomon MBA as the firm’s CEO & Director, Mr. Assaf Oron serves as its Chief Bus. Officer.


Institutional Ownership:

Through their ownership of 20.67% of PHGE’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 30.78% of PHGE, in contrast to 3.31% held by mutual funds. Shares owned by individuals account for 0.74%. As the largest shareholder in PHGE with 2.28% of the stake, MM Asset Management, Inc. holds 684,451 shares worth 684,451. A second-largest stockholder of PHGE, Royce & Associates LP, holds 158,655 shares, controlling over 0.53% of the firm’s shares. Millennium Management LLC is the third largest shareholder in PHGE, holding 87,757 shares or 0.29% stake. With a 0.53% stake in PHGE, the Royce Smaller Companies Growth Fu is the largest stakeholder. A total of 158,655 shares are owned by the mutual fund manager. The Bridgeway Ultra Small Company Mar, which owns about 0.20% of PHGE stock, is the second-largest Mutual Fund holder. It holds 58,700 shares valued at 10977.0. Psagot ETF holds 0.01% of the stake in PHGE, owning 3,081 shares worth 576.0.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PHGE since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PHGE analysts setting a high price target of $10.00 and a low target of $2.00, the average target price over the next 12 months is $5.25. Based on these targets, PHGE could surge 2531.58% to reach the target high and rise by 426.32% to reach the target low. Reaching the average price target will result in a growth of 1281.58% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. PHGE will report FY 2022 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of -$0.93 being high and -$1.01 being low. For PHGE, this leads to a yearly average estimate of -$0.98. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. BiomX Inc. surprised analysts by -$0.01 when it reported -$0.23 EPS against a consensus estimate of -$0.22. The surprise factor in the prior quarter was $0.02. Based on analyst estimates, the high estimate for the next quarter is -$0.20 and the low estimate is -$0.25. The average estimate for the next quarter is thus -$0.23.

Summary of Insider Activity:

Insiders traded PHGE stock several times over the past three months with 0 Buys and 9 Sells. In these transactions, 0 shares were bought while 29,120 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has risen to 62 over the past year. The total number of shares bought during that period was 0 while 640,821 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *